Treatment duration in SVR patients was shorter in TT4 compared to SoC , both overall [ 2515 vs. 3612.1 weeks ] , and for subgroups : G1 [ 35.316.7 vs. 47.32.6 weeks ] , G2 [ 18.37.5 vs. 242.8 weeks ] , G3 [ 15.28.7 vs. 22.83 weeks ] and G4 [ 26.913 vs. 48 weeks ] .